Underwriter |
Biotechnology |
Date |
Offering |
12/31/05 |
Offering |
After-Market |
Adams Harkness |
Martek Biosciences Corp.(MATK) (co-lead) |
1/21/05 |
$49.10 |
$24.60 |
$86.3 |
-50% |
| A.G. Edwards | CombinatoRx Inc. (CRXX) (IPO) |
11/9/05 |
$7 |
$8.18 |
$48.3 |
+17% |
Favrille Inc. (FVRL) (IPO) |
2/2/05 |
$7 |
$4.05 |
$42 |
-42% |
|
Banc of America |
Amylin Pharmaceuticals Inc.(AMLN) |
1/21/05 |
$22 |
$39.92 |
$202.4 |
+81% |
|
Aspreva Pharmaceuticals Corp. (ASPV) (IPO; co-lead) |
3/3/05 |
$11 |
$15.72 |
$91.1 |
+43% |
|
Dendreon Corp. (DNDN) (co-lead) |
12/7/05 |
$4.50 |
$5.42 |
$51.8 |
+20% |
|
ISTA Pharmaceuticals Inc. (ISTA) (co-lead) |
1/20/05 |
$8.88 |
$6.36 |
$56.2 |
-28% |
|
Momenta Pharmaceuticals Inc. (MNTA) |
7/21/05 |
$27.02 |
$22.04 |
$130.4 |
-18% |
|
Threshold Pharmaceuticals Inc. (THLD) (IPO; co-lead) |
2/4/05 |
$7 |
$14.45 |
$37.3 |
+106% |
Baker Watts Stifel |
Accentia Biopharmaceuticals Inc. (ABPI) (IPO) |
10/28/05 |
$8 |
$5.05 |
$19.2 |
-37% |
Bear, Stearns |
CuraGen Corp. (CRGN) (lead) |
8/10/05 |
$5.50 |
$3.08 |
$22 |
-44% |
|
Dynavax Technologies Inc. (DVAX) (lead) |
10/11/05 |
$6.25 |
$4.21 |
$35.75 |
-33% |
|
Favrille Inc. (FVRL) (IPO; lead) |
2/2/05 |
$7 |
$4.05 |
$42 |
-42% |
Bear, Stearns |
Idenix Pharmaceuticals Inc. (IDIX) (co-lead) |
10/26/05 |
$20.61 |
$17.11 |
$150 |
-17% |
|
Keryx Bio-pharmaceuticals Inc. (KERX) (co-lead) |
7/15/05 |
$14.05 |
$14.64 |
$81.2 |
+4% |
|
Myriad Genetics Inc. (MYGN) (co- lead) |
11/3/05 |
$18.50 |
$20.80 |
$148.9 |
+12% |
|
Panacos Pharmaceuticals Inc. (PANC) (co-lead) |
10/6/05 |
$10.50 |
$6.93 |
$86.6 |
-34% |
|
ZymoGenetics Inc. (ZGEN) |
8/4/05 |
$18 |
$17.01 |
$135 |
-6% |
BMO Nesbitt Burns |
Aspreva Pharmaceuticals Corp. (ASPV) (IPO) |
3/3/05 |
$11 |
$15.72 |
$91.1 |
+43% |
|
Neurochem Inc. (NRMX) |
3/4/05 |
$15.30 |
$14.22 |
$61.2 |
-7% |
Brean Murray |
Keryx Biopharmaceuticals Inc. (KERX) |
7/15/05 |
$14.05 |
$14.64 |
$81.2 |
+4% |
C.E. Unterberg, |
Advanced Life Sciences Holdings Inc. (ADLS) (IPO; co-lead) |
8/4/05 |
$5 |
$3.92 |
$32 |
-22% |
|
ISTA Pharmaceuticals Inc. (ISTA) |
1/20/05 |
$8.88 |
$6.36 |
$56.2 |
-28% |
CIBC World Markets |
Arena Pharmaceuticals Inc. (ARNA) (co-lead) |
2/1/05 |
$6 |
$14.21 |
$51.75 |
+137% |
|
Bioenvision Inc. (BIVN) |
2/3/05 |
$8 |
$6.53 |
$60 |
-18% |
|
Cardiome Pharma Corp. (CRME) (co-lead) |
3/18/05 |
$6 |
$10.10 |
$58.65 |
+68% |
|
CoTherix Inc. (CTRX) (co-lead) |
10/6/05 |
$13 |
$10.58 |
$56.4 |
-19% |
CIBC World Markets |
CoTherix Inc. (CTRX) (co-lead) |
2/10/05 |
$8.90 |
$10.58 |
$37.83 |
+19% |
|
Durect Corp. (DRRX) |
11/2/05 |
$5 |
$5.07 |
$41.1 |
+1% |
|
Dynavax Technologies Inc. (DVAX) |
10/11/05 |
$6.25 |
$4.21 |
$35.75 |
-33% |
|
Favrille Inc. (FVRL) (IPO) |
2/2/05 |
$7 |
$4.05 |
$42 |
-42% |
|
Icagen Inc. (ICGN) (IPO) |
2/3/05 |
$8 |
$6.45 |
$40.8 |
-19% |
|
Myogen Inc. (MYOG) |
9/16/05 |
$23.25 |
$30.10 |
$125 |
+29% |
|
Neurochem Inc. (NRMX) |
3/4/05 |
$15.30 |
$14.22 |
$61.2 |
-7% |
|
Nuvelo Inc. (NUVO) |
2/2/05 |
$7.50 |
$8.11 |
$73.31 |
+8% |
|
Point Therapeutics Inc. (POTP) (co-lead) |
11/22/05 |
$3 |
$3.45 |
$27.8 |
+15% |
|
Progenics Pharmaceuticals Inc. (PGNX) (co-lead) |
9/14/05 |
$23.90 |
$25.01 |
$59.75 |
+5% |
|
Progenics Pharmaceuticals Inc. (PGNX) (co-lead) |
4/1/05 |
$15.25 |
$25.01 |
$30.5 |
+64% |
|
Renovis Inc. (RNVS) |
9/23/05 |
$13.50 |
$15.30 |
$54 |
+13% |
|
SeraCare Life Sciences Inc. (SRLS) (lead) |
5/25/05 |
$12.25 |
$8.87 |
$42.6 |
-28% |
|
Threshold Pharmaceuticals Inc. (THLD) (IPO; co-lead) |
2/4/05 |
$7 |
$14.45 |
$37.3 |
+106% |
Citigroup |
Martek Biosciences Corp. (MATK) (co-lead) |
1/21/05 |
$49.10 |
$24.60 |
$86.3 |
-50% |
Credit Suisse First Boston |
Anadys Pharmaceuticals Inc. (ANDS)(co-lead) |
8/4/05 |
$12.40 |
$8.80 |
$71.3 |
-29% |
|
Rigel Pharmaceuticals Inc. (RIGL) (co-lead) |
7/15/05 |
$20.75 |
$8.36 |
$87.1 |
-60% |
|
ViaCell Inc. (VIAC) (IPO; co-lead) |
1/21/05 |
$7 |
$5.62 |
$60.38 |
-20% |
D.A. Davidson & Co. |
Martek Biosciences Corp. (MATK) |
1/21/05 |
$49.10 |
$24.60 |
$86.3 |
-50% |
Delafield Hambrecht |
Nastech Pharmaceutical Co. Inc.(NSTK) |
8/25/05 |
$13.50 |
$14.72 |
$23.3 |
+9% |
Desjardins |
Neurochem Inc. (NRMX) |
3/4/05 |
$15.30 |
$14.22 |
$61.2 |
-7% |
Deutsche Bank |
Momenta Pharmaceuticals Inc.(MNTA) (co-lead) |
7/21/05 |
$27.02 |
$22.04 |
$130.4 |
-18% |
|
Nuvelo Inc. (NUVO) (co-lead) |
2/2/05 |
$7.50 |
$8.11 |
$73.31 |
+8% |
|
Senomyx Inc. (SNMX) (lead) |
11/4/05 |
$14.60 |
$12.12 |
$59 |
-20% |
|
XenoPort Inc. (XNPT) (IPO; co-lead) |
6/2/05 |
$10.50 |
$17.95 |
$52.5 |
+71% |
Ferris, Baker Watts |
BioDelivery Sciences International Inc. (BDSI) (lead) |
9/30/05 |
$2 |
$2.48 |
$8.8 |
+24% |
First Albany |
CV Therapeutics Inc. (CVTX) |
6/29/05 |
$21.60 |
$24.73 |
$180.4 |
+14% |
|
Martek Biosciences Corp. (MATK) |
1/21/05 |
$49.10 |
$24.60 |
$86.3 |
-50% |
|
Myogen Inc. (MYOG) |
9/16/05 |
$23.25 |
$30.10 |
$125 |
+29% |
|
Myriad Genetics Inc. (MYGN) |
11/3/05 |
$18.50 |
$20.80 |
$148.9 |
+12% |
First Associates |
Cardiome Pharma Corp. (CRME) |
3/18/05 |
$6 |
$10.10 |
$58.65 |
+68% |
First Dunbar |
CardioVascular BioTherapeutics Inc. (OTC BB:CVBT) (IPO; lead) |
3/14/05 |
$10 |
$4.55 |
$17.25 |
-55% |
Friedman, Billings, |
Bioenvision Inc. (BIVN) |
2/3/05 |
$8 |
$6.53 |
$60 |
-18% |
|
Tercica Inc. (TRCA) |
2/8/05 |
$8 |
$7.17 |
$55.2 |
-10% |
Fortis Securities |
Neurochem Inc. (NRMX) |
3/4/05 |
$15.30 |
$14.22 |
$61.2 |
-7% |
GMP Securities |
Cardiome Pharma Corp. (CRME) |
3/18/05 |
$6 |
$10.10 |
$58.65 |
+68% |
Goldman, Sachs |
Amylin Pharmaceuticals Inc. (AMLN)(lead) |
8/30/05 |
$31 |
$39.92 |
$157.1 |
+29% |
|
Amylin Pharmaceuticals Inc. (AMLN)(co-lead) |
1/21/05 |
$22 |
$39.92 |
$202.4 |
+81% |
|
Digene Corp. (DIGE) |
11/16/05 |
$28 |
$29.17 |
$64.4 |
+4% |
|
Exelixis Inc. (EXEL) (lead) |
8/17/05 |
$7.75 |
$9.42 |
$50.4 |
+35% |
|
Myogen Inc. (MYOG) (lead) |
9/16/05 |
$23.25 |
$30.10 |
$125 |
+29% |
|
Renovis Inc. (RNVS) (lead) |
9/23/05 |
$13.50 |
$15.30 |
$54 |
+13% |
|
ViroPharma Inc. (VPHM) (co-lead) |
12/7/05 |
$16.75 |
$18.50 |
$173.4 |
+10% |
Granite Financial |
Arena Pharmaceuticals Inc. (ARNA) |
2/1/05 |
$6 |
$14.21 |
$51.75 |
+137% |
GunnAllen |
Accentia Biopharmaceuticals Inc. (ABPI) (IPO) |
10/28/05 |
$8 |
$5.05 |
$19.2 |
-37% |
GunnAllen |
BioDelivery Sciences International Inc. (BDSI) |
9/30/05 |
$2 |
$2.48 |
$8.8 |
+24% |
Harris Nesbitt |
Northfield Laboratories Inc. (NFLD) |
2/4/05 |
$15 |
$13.40 |
$77.63 |
-11% |
|
Tercica Inc. |
2/8/05 |
$8 |
$7.17 |
$55.2 |
-10% |
Jefferies & Co. |
Accentia Biopharmaceuticals Inc. (ABPI) (IPO; lead) |
10/28/05 |
$8 |
$5.05 |
$19.2 |
-37% |
|
Keryx Biopharmaceuticals Inc. (KERX) |
7/15/05 |
$14.05 |
$14.64 |
$81.2 |
+4% |
|
Neose Technologies Inc. (NTEC) |
2/18/05 |
$4 |
$1.94 |
$32.2 |
-52% |
JMP Securities |
Dendreon Corp. (DNDN) |
12/7/05 |
$4.50 |
$5.42 |
$51.8 |
+20% |
|
Genomic Health Inc. (GHDX) (IPO) |
9/29/05 |
$12 |
$9.11 |
$60.2 |
-24% |
|
Myriad Genetics Inc. (MYGN) |
11/3/05 |
$18.50 |
$20.80 |
$148.9 |
+12% |
JP Morgan |
Amylin Pharmaceuticals Inc. (AMLN) |
1/21/05 |
$22 |
$39.92 |
$202.4 |
+81% |
|
Barrier Therapeutics Inc. (BTRX) |
2/10/05 |
$19.50 |
$8.20 |
$39 |
-58% |
|
Bioenvision Inc. (BIVN) (co-lead) |
2/3/05 |
$8 |
$6.53 |
$60 |
-18% |
|
Coley Pharmaceutical Group Inc. (COLY) (IPO; co-lead) |
8/10/05 |
$16 |
$15.16 |
$110.4 |
-5% |
|
Digene Corp. (DIGE) (co-lead) |
11/16/05 |
$28 |
$29.17 |
$64.4 |
+4% |
JP Morgan |
Durect Corp. (DRRX) (co-lead) |
11/2/05 |
$5 |
$5.07 |
$41.1 |
+1% |
|
Genomic Health Inc. (GHDX) (IPO; co-lead) |
9/29/05 |
$12 |
$9.11 |
$60.2 |
-24% |
|
Icagen Inc. (ICGN) (IPO; co-lead) |
2/3/05 |
$8 |
$6.45 |
$40.8 |
-19% |
|
Keryx Biopharmaceuticals Inc. (KERX) (co-lead) |
7/15/05 |
$14.05 |
$14.64 |
$81.2 |
+4% |
|
Myriad Genetics Inc. (MYGN) (co- lead) |
11/3/05 |
$18.50 |
$20.80 |
$148.9 |
+12% |
|
Neose Technologies Inc. (NTEC) |
2/18/05 |
$4 |
$1.94 |
$32.2 |
-52% |
|
Somaxon Pharmaceuticals Inc. (SOMX) (IPO; co-lead) |
12/15/05 |
$11 |
$9.95 |
$55 |
-10% |
|
Telik Inc. (TELK) |
1/28/05 |
$18.75 |
$16.99 |
$151 |
-9% |
|
Vertex Pharmaceuticals Inc. (VRTX) |
6/7/05 |
$13 |
$27.67 |
$175.6 |
+113% |
Lazard Capital |
Ariad Pharmaceuticals Inc. (ARIA) |
8/5/05 |
$7.20 |
$5.85 |
$62.1 |
-19% |
|
Coley Pharmaceutical Group Inc. (COLY) (IPO) |
8/10/05 |
$16 |
$15.16 |
$110.4 |
-5% |
|
CombinatoRx Inc. (CRXX) (IPO) |
11/9/05 |
$7 |
$8.18 |
$48.3 |
+17% |
|
Dendreon Corp. (DNDN) |
12/7/05 |
$4.50 |
$5.42 |
$51.8 |
+20% |
|
Geron Corp. (GERN) |
9/16/05 |
$9 |
$8.61 |
$62.1 |
-4% |
Lazard Capital |
GTx Inc. (GTXI) (co-lead) |
10/11/05 |
$7.80 |
$7.56 |
$49.3 |
-3% |
|
ISTA Pharmaceuticals Inc. (ISTA) |
1/20/05 |
$8.88 |
$6.36 |
$56.2 |
-28% |
|
Myogen Inc. (MYOG) |
9/16/05 |
$23.25 |
$30.10 |
$125 |
+29% |
|
OxiGene Inc. (OXGN) (co-lead) |
12/15/05 |
$3.65 |
$3.97 |
$27.3 |
+9% |
|
Threshold Pharmaceuticals Inc. (THLD) (IPO) |
2/4/05 |
$7 |
$14.45 |
$37.3 |
+106% |
|
ViaCell Inc. (VIAC) (IPO) |
1/21/05 |
$7 |
$5.62 |
$60.38 |
-20% |
|
ViroPharma Inc. (VPHM) |
12/7/05 |
$16.75 |
$18.50 |
$173.4 |
+10% |
|
XenoPort Inc. (XNPT) (IPO) |
6/2/05 |
$10.50 |
$17.95 |
$52.5 |
+71% |
Leerink Swann |
Cardiome Pharma Corp. (CRME) |
3/18/05 |
$6 |
$10.10 |
$58.65 |
+68% |
|
Coley Pharmaceutical Group Inc. (COLY) (IPO) |
8/10/05 |
$16 |
$15.16 |
$110.4 |
-5% |
|
Panacos Pharmaceuticals Inc. (PANC) |
10/6/05 |
$10.50 |
$6.93 |
$86.6 |
-34% |
|
ViaCell Inc. (VIAC) (IPO) |
1/21/05 |
$7 |
$5.62 |
$60.38 |
-20% |
Legg Mason |
Avalon Pharmaceuticals Inc. (AVRX)(IPO) |
9/29/05 |
$10.50 |
$4.50 |
$28.9 |
-57% |
Lehman Brothers |
Ariad Pharmaceuticals Inc. (ARIA) (lead) |
8/5/05 |
$7.20 |
$5.85 |
$62.1 |
-19% |
|
CV Therapeutics Inc. (CVTX) (co-lead) |
6/29/05 |
$21.60 |
$24.73 |
$180.4 |
+14% |
Lehman Brothers |
Genomic Health Inc. (GHDX) (IPO; co-lead) |
9/29/05 |
$12 |
$9.11 |
$60.2 |
-24% |
|
Rigel Pharmaceuticals Inc. (RIGL) (co-lead) |
7/15/05 |
$20.75 |
$8.36 |
$87.1 |
-60% |
|
Sunesis Pharmaceuticals Inc. (SNSS)(IPO; co-lead) |
9/26/05 |
$7 |
$4.98 |
$42 |
-29% |
|
Telik Inc. (TELK) |
1/28/05 |
$18.75 |
$16.99 |
$151 |
-9% |
|
Tercica Inc. (TRCA) (co-lead) |
2/8/05 |
$8 |
$7.17 |
$55.2 |
-10% |
Maxim Group |
BioDelivery Sciences International Inc. (BDSI) |
9/30/05 |
$2 |
$2.48 |
$8.8 |
+24% |
Merrill Lynch & Co. |
Aspreva Pharmaceuticals Corp. (ASPV) (IPO; co-lead) |
3/3/05 |
$11 |
$15.72 |
$91.1 |
+43% |
|
BioMarin Pharmaceutical Inc. (BMRN) (lead) |
7/14/05 |
$7.05 |
$10.78 |
$59.9 |
+53% |
|
Coley Pharmaceutical Group Inc. (COLY) (IPO; co-lead) |
8/10/05 |
$16 |
$15.16 |
$110.4 |
-5% |
|
CV Therapeutics Inc. (CVTX) (co-lead) |
6/29/05 |
$21.60 |
$24.73 |
$180.4 |
+14% |
|
Onyx Pharmaceuticals Inc. (ONXX) (co-lead) |
11/18/05 |
$25.25 |
$28.80 |
$126.3 |
+14% |
|
Vertex Pharmaceuticals Inc. (VRTX) (lead) |
6/7/05 |
$13 |
$27.67 |
$175.6 |
+113% |
|
ZymoGenetics Inc. (ZGEN) (lead) |
8/4/05 |
$18 |
$17.01 |
$135 |
-6% |
Merriman Curhan Ford & Co. |
Advanced Life Sciences Holdings Inc. (ADLS) (IPO) |
8/4/05 |
$5 |
$3.92 |
$32 |
-22% |
Morgan Joseph & Co. |
Arena Pharmaceuticals Inc. (ARNA) |
2/1/05 |
$6 |
$14.21 |
$51.75 |
+137% |
Morgan Stanley & Co. |
Alexion Pharmaceuticals Inc. (ALXN) (lead) |
8/12/05 |
$26.75 |
$20.25 |
$66.9 |
-24% |
|
Amylin Pharmaceuticals Inc. (AMLN) (co-lead) |
1/21/05 |
$22 |
$39.92 |
$202.4 |
+78% |
|
Barrier Therapeutics Inc. (BTRX)(lead) |
2/10/05 |
$19.50 |
$8.20 |
$39 |
-58% |
|
Durect Corp. (DRRX) (co-lead) |
11/2/05 |
$5 |
$5.07 |
$41.1 |
+1% |
|
Idenix Pharmaceuticals Inc. (IDIX) (co-lead) |
10/26/05 |
$20.61 |
$17.11 |
$150 |
-17% |
|
Momenta Pharmaceuticals Inc. (MNTA) (co-lead) |
7/21/05 |
$27.02 |
$22.04 |
$130.4 |
-18% |
|
Onyx Pharmaceuticals Inc. (ONXX)(co-lead) |
11/18/05 |
$25.25 |
$28.80 |
$126.3 |
+14% |
|
Somaxon Pharmaceuticals Inc. (SOMX) (IPO; co-lead) |
12/15/05 |
$11 |
$9.95 |
$55 |
-10% |
|
Threshold Pharmaceuticals Inc. (THLD) (lead) |
10/12/05 |
$10.46 |
$14.45 |
$65.4 |
+38% |
|
XenoPort Inc. (XNPT) (IPO; co-lead) |
6/2/05 |
$10.50 |
$17.95 |
$52.5 |
+71% |
Needham & Co. |
Anadys Pharmaceuticals Inc. (ANDS) |
8/4/05 |
$12.40 |
$8.80 |
$71.3 |
-29% |
Needham & Co. |
Arena Pharmaceuticals Inc. (ARNA) |
2/1/05 |
$6 |
$14.21 |
$51.75 |
+137% |
|
CoTherix Inc. (CTRX) |
10/6/05 |
$13 |
$10.58 |
$56.4 |
-19% |
|
CoTherix Inc. (CTRX) |
2/10/05 |
$8.90 |
$10.58 |
$37.83 |
+19% |
|
Favrille Inc. (FVRL) (IPO) |
2/2/05 |
$7 |
$4.05 |
$42 |
-42% |
|
Geron Corp. (GERN) |
9/16/05 |
$9 |
$8.61 |
$62.1 |
-4% |
|
Martek Biosciences Corp. (MATK) |
1/21/05 |
$49.10 |
$24.60 |
$86.3 |
-50% |
|
Nastech Pharmaceutical Co. Inc. (NSTK) (lead) |
8/25/05 |
$13.50 |
$14.72 |
$23.3 |
+9% |
|
Nuvelo Inc. (NUVO) |
2/2/05 |
$7.50 |
$8.11 |
$73.31 |
+8% |
|
Panacos Pharmaceuticals Inc. (PANC) |
10/6/05 |
$10.50 |
$6.93 |
$86.6 |
-34% |
|
Sunesis Pharmaceuticals Inc. (SNSS) (IPO) |
9/26/05 |
$7 |
$4.98 |
$42 |
-29% |
Nicolaus & Co. |
Accentia Biopharmaceuticals Inc. (ABPI) (IPO) |
10/28/05 |
$8 |
$5.05 |
$19.2 |
-37% |
Oppenheimer & Co. |
Keryx Biopharmaceuticals Inc. (KERX) |
7/15/05 |
$14.05 |
$14.64 |
$81.2 |
+4% |
Orion Securities |
Cardiome Pharma Corp. (CRME) |
3/18/05 |
$6 |
$10.10 |
$58.65 |
+68% |
Pacific Growth Equities |
Aspreva Pharmaceuticals Corp.(ASPV) (IPO) |
3/3/05 |
$11 |
$15.72 |
$91.1 |
+43% |
Pacific Growth Equities |
Barrier Therapeutics Inc. (BTRX) |
2/10/05 |
$19.50 |
$8.20 |
$39 |
-58% |
|
CombinatoRx Inc. (CRXX) (IPO; co-lead) |
11/9/05 |
$7 |
$8.18 |
$48.3 |
+17% |
|
Dynavax Technologies Inc. (DVAX) |
10/11/05 |
$6.25 |
$4.21 |
$35.75 |
-33% |
|
La Jolla Pharmaceutical Co. (LJPC) (lead) |
1/28/05 |
$7 |
$3.70 |
$17.2 |
-47% |
|
Point Therapeutics Inc. (POTP) (co-lead) |
11/22/05 |
$3 |
$3.45 |
$27.8 |
+15% |
|
XenoPort Inc. (XNPT) (IPO) |
6/2/05 |
$10.50 |
$17.95 |
$52.5 |
+71% |
|
ZymoGenetics Inc. (ZGEN) |
8/4/05 |
$18 |
$17.01 |
$135 |
-6% |
Piper Jaffray & Co. |
Acusphere Inc. (ACUS) (lead) |
9/23/05 |
$5.25 |
$5.34 |
$18.7 |
+1% |
|
Anadys Pharmaceuticals Inc. (ANDS) |
8/4/05 |
$12.40 |
$8.80 |
$71.3 |
-29% |
|
Arena Pharmaceuticals Inc. (ARNA)(co-lead) |
2/1/05 |
$6 |
$14.21 |
$51.75 |
+137% |
|
CoTherix Inc. (CTRX) |
10/6/05 |
$13 |
$10.58 |
$56.4 |
-19% |
|
CoTherix Inc. (CTRX) (co-lead) |
2/10/05 |
$8.90 |
$10.58 |
$37.83 |
+19% |
|
CV Therapeutics Inc. (CVTX) |
6/29/05 |
$21.60 |
$24.73 |
$180.4 |
+14% |
|
Genomic Health Inc. (GHDX) (IPO) |
9/29/05 |
$12 |
$9.11 |
$60.2 |
-24% |
|
Myriad Genetics Inc. (MYGN) |
11/3/05 |
$18.50 |
$20.80 |
$148.9 |
+12% |
Piper Jaffray & Co. |
Neurochem Inc. (NRMX) |
3/4/05 |
$15.30 |
$14.22 |
$61.2 |
-7% |
|
Renovis Inc. (RNVS) |
9/23/05 |
$13.50 |
$15.30 |
$54 |
+13% |
|
Somaxon Pharmaceuticals Inc.(SOMX) (IPO) |
12/15/05 |
$11 |
$9.95 |
$55 |
-10% |
|
ViroPharma Inc. (VPHM) (co-lead) |
12/7/05 |
$16.75 |
$18.50 |
$173.4 |
+10% |
|
ZymoGenetics Inc. (ZGEN) |
8/4/05 |
$18 |
$17.01 |
$135 |
-6% |
Punk, Ziegel & Co. |
Keryx Biopharmaceuticals Inc. (KERX) |
7/15/05 |
$14.05 |
$14.64 |
$81.2 |
+4% |
|
Zonagen Inc. (ZONA) (co-lead) |
1/27/05 |
$4 |
$5.11 |
$20.2 |
+28% |
Robert W. Baird & Co. |
Meridian Bioscience Inc. (VIVO) (lead) |
9/16/05 |
$17.50 |
$20.14 |
$31.5 |
+15% |
|
Tercica Inc. (TRCA) |
2/8/05 |
$8 |
$7.17 |
$55.2 |
-10% |
Rodman & Renshaw |
Geron Corp. (GERN) |
9/16/05 |
$9 |
$8.61 |
$62.1 |
-4% |
SG Cowen & Co. |
Anadys Pharmaceuticals Inc. (ANDS) (co-lead) |
8/4/05 |
$12.40 |
$8.80 |
$71.3 |
-29% |
|
Ariad Pharmaceuticals Inc. (ARIA) |
8/5/05 |
$7.20 |
$5.85 |
$62.1 |
-19% |
|
CombinatoRx Inc. (CRXX) (IPO; co-lead) |
11/9/05 |
$7 |
$8.18 |
$48.3 |
+17% |
|
CV Therapeutics Inc. (CVTX) |
6/29/05 |
$21.60 |
$24.73 |
$180.4 |
+14% |
|
Digene Corp. (DIGE) |
11/16/05 |
$28 |
$29.17 |
$64.4 |
+4% |
|
Geron Corp. (GERN) |
9/16/05 |
$9 |
$8.61 |
$62.1 |
-4% |
SG Cowen & Co. |
GTx Inc. (GTXI) (co-lead) |
10/11/05 |
$7.80 |
$7.56 |
$49.3 |
-3% |
|
Momenta Pharmaceuticals Inc. (MNTA) |
7/21/05 |
$27.02 |
$22.04 |
$130.4 |
-18% |
|
Northfield Laboratories Inc. (NFLD)(co-lead) |
2/4/05 |
$15 |
$13.40 |
$77.63 |
-11% |
|
OxiGene Inc. (OXGN) (co-lead) |
12/15/05 |
$3.65 |
$3.97 |
$27.3 |
+9% |
|
Panacos Pharmaceuticals Inc. (PANC) (co-lead) |
10/6/05 |
$10.50 |
$6.93 |
$86.6 |
-34% |
|
Renovis Inc. (RNVS) |
9/23/05 |
$13.50 |
$15.30 |
$54 |
+13% |
|
Sunesis Pharmaceuticals Inc. (SNSS) (IPO; co-lead) |
9/26/05 |
$7 |
$4.98 |
$42 |
-29% |
|
Tercica Inc. (TRCA) (co-lead) |
2/8/05 |
$8 |
$7.17 |
$55.2 |
-10% |
|
ViroPharma Inc. (VPHM) |
12/7/05 |
$16.75 |
$18.50 |
$173.4 |
+10% |
|
Vivus Inc. (VVUS) (co-lead) |
3/10/05 |
$3.40 |
$2.96 |
$21.25 |
-13% |
SunTrust Robinson, Humphrey |
Nastech Pharmaceutical Co. Inc. (NSTK) |
8/25/05 |
$13.50 |
$14.72 |
$23.3 |
+9% |
Susquehanna Financial |
Avalon Pharmaceuticals Inc. (AVRX) (IPO) |
9/29/05 |
$10.50 |
$4.50 |
$28.9 |
-57% |
ThinkEquity Partners |
Advanced Life Sciences Holdings Inc. (ADLS) (IPO; co-lead) |
8/4/05 |
$5 |
$3.92 |
$32 |
-22% |
Thomas Weisel Partners |
CoTherix Inc. (CTRX) |
2/10/05 |
$8.90 |
$10.58 |
$37.83 |
+19% |
|
Digene Corp. (DIGE) (co-lead) |
11/16/05 |
$28 |
$29.17 |
$64.4 |
+4% |
Thomas Weisel Partners |
Genomic Health Inc. (GHDX) (IPO) |
9/29/05 |
$12 |
$9.11 |
$60.2 |
-24% |
|
ISTA Pharmaceuticals Inc. (ISTA)(co-lead) |
1/20/05 |
$8.88 |
$6.36 |
$56.2 |
-28% |
|
SeraCare Life Sciences Inc. (SRLS) |
5/25/05 |
$12.25 |
$8.87 |
$42.6 |
-28% |
|
Somaxon Pharmaceuticals Inc. (SOMX) (IPO) |
12/15/05 |
$11 |
$9.95 |
$55 |
-10% |
UBS Investment Bank |
Bioenvision Inc. (BIVN) (co-lead) |
2/3/05 |
$8 |
$6.53 |
$60 |
-18% |
|
Cardiome Pharma Corp. (CRME) (co-lead) |
3/18/05 |
$6 |
$10.10 |
$58.65 |
+68% |
|
CoTherix Inc. (CTRX) (co-lead) |
10/6/05 |
$13 |
$10.58 |
$56.4 |
-19% |
|
Geron Corp. (GERN) (lead) |
9/16/05 |
$9 |
$8.61 |
$62.1 |
-4% |
|
Icagen Inc. (ICGN) (IPO; co-lead) |
2/3/05 |
$8 |
$6.45 |
$40.8 |
-19% |
|
Myriad Genetics Inc. (MYGN) (co-lead) |
11/3/05 |
$18.50 |
$20.80 |
$148.9 |
+12% |
|
Neose Technologies Inc. (NTEC) (lead) |
2/18/05 |
$4 |
$1.94 |
$32.20 |
-52% |
|
Neurochem Inc. (NRMX) (lead) |
3/4/05 |
$15.30 |
$14.22 |
$61.20 |
-7% |
|
Northfield Laboratories Inc. (NFLD) (co-lead) |
2/4/05 |
$15 |
$13.40 |
$77.63 |
-11% |
|
Nuvelo Inc. (NUVO) (co-lead) |
2/2/05 |
$7.50 |
$8.11 |
$73.31 |
+8% |
|
Progenics Pharmaceuticals Inc. (PGNX) (co-lead) |
9/14/05 |
$23.90 |
$25.01 |
$59.75 |
+5% |
UBS Investment Bank |
Progenics Pharmaceuticals Inc. (PGNX) (lead) |
6/10/05 |
$19.25 |
$25.01 |
$29.50 |
+30% |
|
Progenics Pharmaceuticals Inc. (PGNX) (co-lead) |
4/1/05 |
$15.25 |
$25.01 |
$30.50 |
+64% |
|
Telik Inc. (TELK) (lead) |
1/28/05 |
$18.75 |
$16.99 |
$151 |
-9% |
|
Vertex Pharmaceuticals Inc. (VRTX) |
6/7/05 |
$13 |
$27.67 |
$175.6 |
+113% |
|
ViaCell Inc. (VIAC) (IPO; co-lead) |
1/21/05 |
$7 |
$5.62 |
$60.38 |
-20% |
Wachovia Capital Markets |
Amylin Pharmaceuticals Inc. (AMLN) |
1/21/05 |
$22 |
$39.92 |
$202.4 |
+81% |
|
Vivus Inc. (VVUS) (co-lead) |
3/10/05 |
$3.40 |
$2.94 |
$21.25 |
-13% |
WBB Securities |
Geron Corp. (GERN) |
9/16/05 |
$9 |
$8.61 |
$62.1 |
-4% |
Wells Fargo Securities |
Neurochem Inc. (NRMX) |
3/4/05 |
$15.30 |
$14.22 |
$61.2 |
-7% |
William Blair & Co. |
SeraCare Life Sciences Inc. (SRLS) |
5/25/05 |
$12.25 |
$8.87 |
$42.6 |
-28% |
|
Threshold Pharmaceuticals Inc. (THLD) (IPO) |
2/4/05 |
$7 |
$14.45 |
$37.3 |
+106% |
WR Hambrecht + Co. |
Avalon Pharmaceuticals Inc. (AVRX)(IPO; lead) |
9/29/05 |
$10.50 |
$4.50 |
$28.9 |
-57% |
|
Durect Corp. (DRRX) (co-lead) |
11/2/05 |
$5 |
$5.07 |
$41.1 |
+1% |
|
Zonagen Inc. (ZONA) (co-lead) |
1/27/05 |
$4 |
$5.11 |
$20.2 |
+28% |
Notes: | ||||||
* The financings in this chart include only public offerings of stock in the U.S. The data were compiled primarily from BioWorld Financial Watch's monthly financing charts covering the period from Jan. 1 to Dec. 31, 2005. The gross proceed totals include money raised through overallotment options. Offering prices were adjusted to reflect stock splits, where applicable. | ||||||
Unless otherwise noted, shares are traded on the Nasdaq exchange. | ||||||
OTC BB = Over-the-Counter Bulletin Board. | ||||||
To read more on related topics, click on one of the words below.